340 related articles for article (PubMed ID: 15518555)
1. Characterization of the heptad repeat regions, HR1 and HR2, and design of a fusion core structure model of the spike protein from severe acute respiratory syndrome (SARS) coronavirus.
Xu Y; Zhu J; Liu Y; Lou Z; Yuan F; Liu Y; Cole DK; Ni L; Su N; Qin L; Li X; Bai Z; Bell JI; Pang H; Tien P; Gao GF; Rao Z
Biochemistry; 2004 Nov; 43(44):14064-71. PubMed ID: 15518555
[TBL] [Abstract][Full Text] [Related]
2. Solution structure of the severe acute respiratory syndrome-coronavirus heptad repeat 2 domain in the prefusion state.
Hakansson-McReynolds S; Jiang S; Rong L; Caffrey M
J Biol Chem; 2006 Apr; 281(17):11965-71. PubMed ID: 16507566
[TBL] [Abstract][Full Text] [Related]
3. Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.
Bosch BJ; Martina BE; Van Der Zee R; Lepault J; Haijema BJ; Versluis C; Heck AJ; De Groot R; Osterhaus AD; Rottier PJ
Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8455-60. PubMed ID: 15150417
[TBL] [Abstract][Full Text] [Related]
4. Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.
Liu S; Xiao G; Chen Y; He Y; Niu J; Escalante CR; Xiong H; Farmar J; Debnath AK; Tien P; Jiang S
Lancet; 2004 Mar; 363(9413):938-47. PubMed ID: 15043961
[TBL] [Abstract][Full Text] [Related]
5. Structural characterization of the fusion-active complex of severe acute respiratory syndrome (SARS) coronavirus.
Ingallinella P; Bianchi E; Finotto M; Cantoni G; Eckert DM; Supekar VM; Bruckmann C; Carfi A; Pessi A
Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8709-14. PubMed ID: 15161975
[TBL] [Abstract][Full Text] [Related]
6. Construct design, biophysical, and biochemical characterization of the fusion core from mouse hepatitis virus (a coronavirus) spike protein.
Xu Y; Cole DK; Lou Z; Liu Y; Qin L; Li X; Bai Z; Yuan F; Rao Z; Gao GF
Protein Expr Purif; 2004 Nov; 38(1):116-22. PubMed ID: 15477089
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core.
Xu Y; Lou Z; Liu Y; Pang H; Tien P; Gao GF; Rao Z
J Biol Chem; 2004 Nov; 279(47):49414-9. PubMed ID: 15345712
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for coronavirus-mediated membrane fusion. Crystal structure of mouse hepatitis virus spike protein fusion core.
Xu Y; Liu Y; Lou Z; Qin L; Li X; Bai Z; Pang H; Tien P; Gao GF; Rao Z
J Biol Chem; 2004 Jul; 279(29):30514-22. PubMed ID: 15123674
[TBL] [Abstract][Full Text] [Related]
9. Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.
Yuan K; Yi L; Chen J; Qu X; Qing T; Rao X; Jiang P; Hu J; Xiong Z; Nie Y; Shi X; Wang W; Ling C; Yin X; Fan K; Lai L; Ding M; Deng H
Biochem Biophys Res Commun; 2004 Jul; 319(3):746-52. PubMed ID: 15184046
[TBL] [Abstract][Full Text] [Related]
10. Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors.
Zhu J; Xiao G; Xu Y; Yuan F; Zheng C; Liu Y; Yan H; Cole DK; Bell JI; Rao Z; Tien P; Gao GF
Biochem Biophys Res Commun; 2004 Jun; 319(1):283-8. PubMed ID: 15158473
[TBL] [Abstract][Full Text] [Related]
11. Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS-CoV): in search of potent SARS-CoV entry inhibitors.
Chu LH; Chan SH; Tsai SN; Wang Y; Cheng CH; Wong KB; Waye MM; Ngai SM
J Cell Biochem; 2008 Aug; 104(6):2335-47. PubMed ID: 18442051
[TBL] [Abstract][Full Text] [Related]
12. Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors.
Liu IJ; Kao CL; Hsieh SC; Wey MT; Kan LS; Wang WK
Antiviral Res; 2009 Jan; 81(1):82-7. PubMed ID: 18983873
[TBL] [Abstract][Full Text] [Related]
13. Biophysical characterization of HRC peptide analogs interaction with heptad repeat regions of the SARS-coronavirus Spike fusion protein core.
Yan Z; Tripet B; Hodges RS
J Struct Biol; 2006 Aug; 155(2):162-75. PubMed ID: 16765058
[TBL] [Abstract][Full Text] [Related]
14. Structure of a proteolytically resistant core from the severe acute respiratory syndrome coronavirus S2 fusion protein.
Supekar VM; Bruckmann C; Ingallinella P; Bianchi E; Pessi A; CarfĂ A
Proc Natl Acad Sci U S A; 2004 Dec; 101(52):17958-63. PubMed ID: 15604146
[TBL] [Abstract][Full Text] [Related]
15. Six-helix bundle assembly and analysis of the central core of mumps virus fusion protein.
Liu Y; Zhu J; Feng MG; Tien P; Gao GF
Arch Biochem Biophys; 2004 Jan; 421(1):143-8. PubMed ID: 14678795
[TBL] [Abstract][Full Text] [Related]
16. Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus.
Gao J; Lu G; Qi J; Li Y; Wu Y; Deng Y; Geng H; Li H; Wang Q; Xiao H; Tan W; Yan J; Gao GF
J Virol; 2013 Dec; 87(24):13134-40. PubMed ID: 24067982
[TBL] [Abstract][Full Text] [Related]
17. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex.
Bosch BJ; van der Zee R; de Haan CA; Rottier PJ
J Virol; 2003 Aug; 77(16):8801-11. PubMed ID: 12885899
[TBL] [Abstract][Full Text] [Related]
18. Structural characterization of the SARS-coronavirus spike S fusion protein core.
Tripet B; Howard MW; Jobling M; Holmes RK; Holmes KV; Hodges RS
J Biol Chem; 2004 May; 279(20):20836-49. PubMed ID: 14996844
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of heptad repeat 1 and 2 mutants of the spike protein of severe acute respiratory syndrome coronavirus.
Chan WE; Chuang CK; Yeh SH; Chang MS; Chen SS
J Virol; 2006 Apr; 80(7):3225-37. PubMed ID: 16537590
[TBL] [Abstract][Full Text] [Related]
20. Design and characterization of viral polypeptide inhibitors targeting Newcastle disease virus fusion.
Zhu J; Jiang X; Liu Y; Tien P; Gao GF
J Mol Biol; 2005 Dec; 354(3):601-13. PubMed ID: 16253271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]